Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03018223 · OUTCOME

Incidence of Grade II-IV Acute Graft vs. Host Disease (GVHD)

Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT · Source last updated 2021-09-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
100 days post hematopoietic cell transplant (HCT)

What was measured

Cumulative incidence of grade II-IV acute GVHD by day 100 after HCT. Acute GVHD organ staging and assessment of overall grade will use standard consensus criteria. The cumulative incidence of acute and chronic GVHD will be estimated, considering malignancy relapse and non-relapse death as competing risk events.

Groups in this outcome

Conditioning/HCT/GVHD Prophylaxis

Pre-HCT Conditioning, HCT, GVHD Prophylaxis.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Conditioning/HCT/GVHD Prophylaxis32

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Conditioning/HCT/GVHD Prophylaxis18.8Not reported7.534.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        7.5
        upper Limit
        34.0
        value
        18.8
denoms
  1. counts
    1. group Id
      OG000
      value
      32
    units
    Participants
description
Cumulative incidence of grade II-IV acute GVHD by day 100 after HCT. Acute GVHD organ staging and assessment of overall grade will use standard consensus criteria. The cumulative incidence of acute and chronic GVHD will be estimated, considering malignancy relapse and non-relapse death as competing risk events.
dispersion Type
95% Confidence Interval
groups
  1. description
    Pre-HCT Conditioning, HCT, GVHD Prophylaxis.
    id
    OG000
    title
    Conditioning/HCT/GVHD Prophylaxis
param Type
NUMBER
reporting Status
POSTED
time Frame
100 days post hematopoietic cell transplant (HCT)
title
Incidence of Grade II-IV Acute Graft vs. Host Disease (GVHD)
type
PRIMARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice